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BACKGROUND: There is an unexplained male predominance in the incidence of oesophageal adenocarcinoma, and the sex-specific
distribution of its risk factors in the general population is not known.
METHODS: A random sample of Swedish citizens aged 40–79 years completed a questionnaire for assessment of the prevalence of five
risk factors for oesophageal adenocarcinoma: reflux symptoms, body mass index, tobacco smoking habits, socioeconomic status, and
use of non-steroidal anti-inflammatory drugs (NSAIDs). Logistic regression was used to calculate odds ratios (ORs) with 95%
confidence intervals (CIs) to evaluate the association of these risk factors, separately and combined, with male sex, with women as
reference.
RESULTS: Among 6969 invited people, 4906 (70.4%) completed the questionnaire. Adjusted prevalence estimates showed a negative
association with male sex with regard to reflux disease (OR¼0.70, 95% CI¼0.58–0.84), whereas overweight (OR¼1.98, 95%
CI¼1.72–2.27) and obesity (OR¼1.22, 95% CI¼1.01–1.47), previous smoking (OR¼1.50, 95% CI¼1.30–1.72), and no NSAID
use (OR¼1.35, 95% CI¼1.15–1.49) were positively associated.
CONCLUSIONS: Exposure to some but not all established risk factors for oesophageal adenocarcinoma seems to be more common in
men than in women, but the differences are small and unlikely to explain the male predominance of this tumour.
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The striking male predominance of oesophageal adenocarcinoma,
with a male-to-female ratio ranging from 7:1 to 10:1 (Vizcaino
et al, 2002), remains unexplained. The rapid rise in the incidence
of oesophageal adenocarcinoma in Western societies during recent
decades (Brown et al, 2008) has been especially pronounced in
men (Vizcaino et al, 2002). Epidemiological studies evaluating the
hypothesis that sex hormones have a role, including hormonal
replacement therapy (Lindblad et al, 2006) and reproductive
factors (Lagergren and Jansson, 2005), have not provided support
for oestrogen as an aetiological factor, whereas reports on anti-
androgen therapy have shown mixed results (Lagergren and
Nyren, 1998; Cooper et al, 2009). Furthermore, there seem to be no
clear sex differences in the strength of the associations between
known risk factors and risk of oesophageal adenocarcinoma
(Hampel et al, 2005; Lindblad et al, 2005; Kubo and Corley, 2006).
Thus, the explanation underlying the strong and age-specific male
predominance in oesophageal adenocarcinoma remains unknown
(Rutegard et al, 2010). The principal aetiological factors are gastro-
oesophageal reflux (reflux) (Lagergren et al, 1999a; Shaheen and
Ransohoff, 2002) and a high body mass index (BMI; Chow et al,
1998; Lagergren et al, 1999b; Kubo and Corley, 2006; Abnet et al,
2008), whereas tobacco smoking (Gammon et al, 1997; Lagergren
et al, 2000; Freedman et al, 2007) and low socioeconomic status
(Jansson et al, 2005) are weaker factors; regular use of
non-steroidal anti-inflammatory drugs (NSAIDs) seems to be
protective (Abnet et al, 2009). The sex-specific distribution of the
exposure to these five factors in an unselected general population
has not hitherto been estimated. We hypothesised that these risk
factors for oesophageal adenocarcinoma, individually or in
different combinations, are unevenly distributed between men
and women. Furthermore, such sex differences might relate to pre-
and post-menopausal age. To test these hypotheses, we conducted
a population-based prevalence study in Sweden.
MATERIALS AND METHODS
This was a population-based, cross-sectional study, with data
collection during the period April–June 2008. The exposure
prevalence rates of the five known aetiological factors, that is,
reflux, BMI, tobacco smoking, socioeconomic status, and NSAID
use, were compared between men and women in a random
Swedish population sample of age 40–79 years. Random sampling
and data collection were carried out by Statistics Sweden, a
Swedish authority that holds the highly complete and updated
nation-wide Swedish Total Population Register, which was used for
this study. The sampling was performed to mimic the age and sex
distribution of oesophageal and gastric adenocarcinoma according
to the new cases reported to the Swedish Cancer Register in the
year 2006. This provided a sample with a higher proportion of
women and a slightly younger female population than had the
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ysample been matched to oesophageal adenocarcinoma only. This
age discrepancy was adjusted for in all analyses, but influenced the
unadjusted prevalence, whereas all results were stratified by sex.
A validated questionnaire (Lane et al, 2002) was sent to the
selected individuals. Up to two reminding letters were sent to
non-responders.
The questionnaire contained questions about the five study
exposures, together with some general characteristics, including
sex, age, and physical activity. Reflux was defined as heartburn
or regurgitation occurring at least once a week during the last
3 months, or at least weekly use of anti-reflux medication
during the same time period, a definition commonly used
in epidemiological research. In addition, a reflux variable based
on the Montreal definition (Vakil et al, 2006), including both
frequency and severity of symptoms, was evaluated. Current BMI
value was calculated as body weight in kilograms divided
by the square of body height in metres. Cutoffs for BMI
were predetermined and based on the World Health Organization
classification of overweight and obesity (WHO, 2008). A subject
with a BMI value below 18.5kgm
 2 was considered to be
underweight, a value of 18.5–24.9kgm
 2 was regarded as normal,
25–29.9kgm
 2 was defined as overweight, and 30kgm
 2
and above as obese. Tobacco smoking status was defined
as current, former, or never smoker. If the participants had
ever smoked ‘one or more cigarettes a day for a year or more’
and ‘smoked within the last 3 months’, they were classified
as current smokers. Previous smokers were those who had
ever smoked ‘one or more cigarettes a day for a year or more’,
but had not smoked during the past 3 months. Never smokers
had never smoked ‘one or more cigarettes a day for a year
or more’. Formal education was used as a proxy for socioeconomic
status, as supported by previous findings (Robert and House,
1996; Fuchs, 2004). Length of education was categorised into
less than or equal to 9 years, 10–12 years, or more than 12 years.
The use of NSAID was defined as the use of predefined and
well-known brands of NSAIDs within the last 3 months. This
was categorised into four groups, namely, no use of NSAIDs
(or less than once a month), monthly use, weekly use, and daily
use, in accordance with previous research (Abnet et al, 2009).
Aspirin was included in the NSAID variable, as it is considered
equivalent to NSAIDs with regard to cancer preventive effects
(Abnet et al, 2009).
Statistical analysis
The male and female prevalence rates of reflux, high BMI, tobacco
smoking, socioeconomic status, and use of NSAIDs were
compared, using exposure frequencies and relative risk estima-
tions. To allow adjustment for potential confounding factors,
unconditional multivariable logistic regression was used to
calculate odds ratios (ORs) with 95% confidence intervals (CIs).
In these analyses, aetiological factors were the exposures and male
sex was the outcome, using female sex as reference. Two
predefined multivariable models were applied, a basic model
adjusted only for age (categorised into three groups: o60, 60–70,
or 470 years) and the full model further adjusted for physical
activity (several times a week, once a week, or less than once a
week), reflux (no or yes), BMI (o25, 25–29.9, or X30kgm
 2),
tobacco smoking status (never, previous, or current smoker),
education (p9, 10–12, or 412 years), and NSAID use (ever or
never). Physical activity was included as a potential confounder
because of reported differences between the sexes and a putative
association with the evaluated risk factors (Young et al, 2009).
Goodness-of-fit (Hosmer and Lemeshow, 1980) was found
adequate for both models (data not shown). Furthermore,
predefined exploratory analyses were conducted by combining
study variables, in which individuals with non-exposure
were compared with exposed individuals with regard to given
combinations of the included variables. For example, individuals
with BMI o25kgm
 2, without reflux, who had never smoked
were compared with individuals with BMI X25kgm
 2,
with reflux, who were ever smokers. Intermediate groups of
exposure are not presented, but were included in the model,
thus using all observations. Owing to the expected small numbers
in each category, these analyses were only age-adjusted.
Finally, the cutoff of 50 years was used to delineate the presumed
effects of menopause, but power was inadequate. Instead, the
sample median (65 years) was used to allow age-stratified analyses.
All analyses were conducted using STATA 10.1 (StataCorp, College
Station, TX, USA).
The Regional Ethics Committee in Stockholm approved the study.
RESULTS
Among 6969 invited people, the 4906 (70.4%) who responded to
the questionnaire were included in this study. Of them, 3220
(65.6%) were men and 1686 (34.4%) were women, with participa-
tion rates of 69.5 and 72.6%, respectively. Non-participation was
more common in younger age groups; 53.0% of those invited
between the ages of 40 and 44 years responded, whereas 75.2% of
the ones aged 75–79 years replied. The mean ages of the male and
female participants were 65.2 (s.d.¼9.4) and 63.9 (s.d.¼10.7)
years, respectively. The physical activity level was similar in men
and women (data not shown). Results from the logistic regression
analyses follow, but as the results were similar in the two adjusted
models, only the full model is presented.
Reflux was observed in 10.2 and 13.5% of men and women,
respectively (Table 1). The adjusted logistic regression analysis
identified a statistically significantly lower prevalence of reflux in
men than in women (OR¼0.70, 95% CI¼0.58–0.84; Table 1). Use
of the Montreal definition of reflux did not notably alter the sex
difference in prevalence (6.2% for men and 8.5% for women).
Among men, 46.8% were overweight and 13.5% were obese,
whereas the corresponding prevalence rates for women were 31.9
and 15.1%, respectively (Table 1). After adjustment for other risk
factors and other potential confounders in the full regression
model, there was an almost two-fold increase in the odds of being
overweight in men, as compared with women (OR¼1.98, 95%
CI¼1.72–2.27). The prevalence of obesity was also higher in men,
but this sex-associated difference was less marked (OR¼1.22, 95%
CI¼1.01–1.47; Table 1).
The proportion of never smokers was higher among women
than among men (52.8 and 45.3%, respectively). Former smoking
was more prevalent in men (37.6 vs 28.5%), whereas prevalence of
current smoking was similar in the two sexes (Table 1). Compared
with never smokers, results from the logistic regression analysis
suggested that previous smoking, adjusted for all other factors, was
50% more common among men than among women (OR¼1.50,
95% CI¼1.30–1.72), whereas current smoking was slightly, and
non-statistically significantly overrepresented among men
(OR¼1.18, 95% CI¼0.98–1.42; Table 1).
A higher proportion of women than men had more than 12 years
of formal education (28.2 vs 23.9%). The intermediate educational
level (9–12 years) was more common in men than in women (12.3
and 7.1%, respectively). The prevalence of less than 9 years of
education was similar between the sexes (Table 1). The adjusted
analyses revealed that, compared with the highest education level,
the intermediate level was twice as common in men than in
women, (OR¼2.10, 95% CI¼1.65–2.68), whereas the lowest
education level was equally distributed between the sexes
(OR¼1.07, 95% CI¼0.92–1.24; Table 1).
Use of NSAIDs was more common among women than
among men in all subcategories, and 18.9% of men and 21.1%
of women were daily users (Table 1). The adjusted estimates
revealed that with daily use as reference, weekly (OR¼0.83,
Sex differences in risk factors for oesophageal adenocarcinoma
M Rutega ˚rd et al
736
British Journal of Cancer (2010) 103(5), 735–740 & 2010 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
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1.15) use was non-significantly less common in men than in
women. Furthermore, non-use of NSAIDs was more prevalent in
men (OR¼1.35, 95% CI¼1.14–1.59; Table 1).
Simultaneous exposures to combinations of some or all study
variables are shown in Table 2. A marked male predominance was
observed in combined exposure to reflux, high BMI, and NSAID
use (OR¼1.62, 95% CI¼1.09–2.42), the combination of reflux,
high BMI, tobacco smoking, and NSAID use (OR¼2.59, 95%
CI¼1.42–4.72), and the combined exposure to all five studied
factors (OR¼2.76, 95% CI¼1.21–6.32). Evaluated associations of
male sex with other combinations of risk factors were not
statistically significant (Table 2).
Stratifying for age by using the sample median of 65 years
produced logistic regression results as shown in Table 3. Over-
weight (OR¼2.41, 95% CI¼1.99–2.93 vs OR¼1.63, 95%
CI¼1.33–1.99) and obesity (OR¼1.74, 95% CI¼1.33–2.29 vs
OR¼0.87, 95% CI¼0.67–1.13) seemed to be more associated with
male sex compared with female sex at younger ages. Previous
(OR¼1.04, 95% CI¼0.86–1.27 vs OR¼2.18, 95% CI¼1.79–2.67)
and current (OR¼0.97, 95% CI¼0.76–1.24 vs OR¼1.41, 95%
CI¼1.05–1.90) smoking was less strongly linked to men at
younger ages than to men at older ages. Younger men seemed to
have a shorter education than younger women (p9 years:
OR¼1.38, 95% CI¼1.13–1.67), whereas this association was
reversed at older age (p9 years: OR¼0.77, 95% CI¼0.61–0.98).
Finally, no use of NSAID seemed equally more prevalent in
younger and older men (OR¼1.26, 95% CI¼0.95–1.67 vs
OR¼1.31, 95% CI¼1.07–1.61; Table 3).
DISCUSSION
This study of a random sample of the general population indicates
that exposure to risk factors for oesophageal adenocarcinoma is
more common among men than among women. There was no
male predominance regarding reflux alone, but each of the risk
factors, namely, high BMI, tobacco smoking, and low socio-
economic status, was more common among men and use of
NSAIDs was less prevalent among men. Combinations of these risk
factors were more prevalent in men only when use of NSAID was
included. Age-stratified analyses indicated that high BMI was more
common in men at a younger age.
The advantages of this study include a population-based design
with a high participation rate, which reduces the risk of selection
bias and facilitates generalisation. Moreover, the large sample size
allowed robust estimations, combining of study variables and
stratification. The availability of data on all known risk factors
allowed adjustment for potential confounding. There are, however,
several limitations. The use of questionnaires to evaluate variables,
such as height and weight, could introduce misclassification, and
women might underestimate weight and overestimate height more
than men (Flood et al, 2000). This effect, however, is mostly
mediated by socioeconomic differences (Bostrom and Diderichsen,
Table 1 Sex-specific prevalence rates and results of logistic regression analyses
Men: N¼3220 (65.6%) Women: N¼1686 (34.4%) Full model
a
Selected risk factors N (%) N (%) OR (95% CI)
Reflux
b
No 2711 (84.2) 1301 (77.2) 1.00 (reference)
Yes 330 (10.2) 227 (13.5) 0.70 (0.58–0.84)
Missing 179 (5.6) 158 (9.4)
Body Mass Index
o25 (normal weight) 1120 (34.8) 790 (46.9) 1.00 (reference)
25–30 (overweight) 1508 (46.8) 538 (31.9) 1.98 (1.72–2.27)
X30 (obese) 435 (13.5) 254 (15.1) 1.22 (1.01–1.47)
Missing 157 (4.9) 104 (6.2)
Tobacco smoking status
Never smoker 1459 (45.3) 890 (52.8) 1.00 (reference)
Former smoker 1210 (37.6) 480 (28.5) 1.50 (1.30–1.72)
Current smoker 445 (13.8) 233 (13.8) 1.18 (0.98–1.42)
Missing 106 (3.3) 83 (4.9)
Formal education (proxy for SES)
412 years 771 (23.9) 475 (28.2) 1.00 (reference)
9–12 years 397 (12.3) 119 (7.1) 2.10 (1.65–2.68)
p9 years 1953 (60.7) 1034 (61.3) 1.07 (0.92–1.24)
Missing 99 (3.1) 58 (3.4)
NSAID use
Daily 608 (18.9) 356 (21.1) 1.00 (reference)
Weekly 216 (6.7) 170 (10.1) 0.83 (0.64–1.06)
Monthly 217 (6.7) 156 (9.3) 0.89 (0.68–1.15)
No use
c 2023 (62.8) 926 (54.9) 1.35 (1.14–1.59)
Missing 156 (4.8) 78 (4.6)
Abbreviations: CI¼confidence interval; N¼number; NSAID¼non-steroidal anti-inflammatory drug; OR¼odds ratio; SES¼socioeconomic status. Sex-specific prevalence rates
and results of logistic regression analyses with OR and 95% CIs values in a randomly selected sample of 4906 Swedish citizens, using risk factors as exposures and male sex as
outcome.
aAdjusted for age, physical activity, reflux, education, body mass index, smoking status, NSAID use.
bDefined as at least weekly symptoms of acid regurgitation and/or
heartburn and/or weekly use of gastro-oesophageal reflux disease treatment, such as proton pump inhibitors, antacids, or H2-blockers.
cNo use or less than once a month.
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could introduce biased results, but the extent of missing data was
limited and any such effect should be non-differential and
therefore not explain the positive associations. Risk factors for
cancer development are commonly considered to have an impact
over a number of years. It might therefore be argued that a
younger population sample should have been chosen to reflect the
risk factors when cancer development was initiated. However, the
induction times for the mechanisms that cause oesophageal
adenocarcinoma are not known, and habits already established
in adulthood may not readily be prone to change (Prattala et al,
1994; Mulder et al, 1998; Benzies et al, 2008). Residual confound-
ing from known risk factors and confounding from unknown
variables are threats to all observational studies. However,
adjustments were made for all known risk factors and the
categorisation was comparatively detailed. Some data suggest that
infection with Helicobacter pylori prevents the development of
oesophageal adenocarcinoma (Rokkas et al, 2007), but this
possible negative association remains to be established. Moreover,
data regarding a possible sex difference in H. pylori prevalence are
conflicting, at most showing a weak male predominance of
infection in adults (de Martel and Parsonnet, 2006). Multiple
testing is another issue to be considered in this study, as several
analyses were conducted and we combined various risk factors;
however, this concern should be mitigated by the fact that the
hypotheses were predefined and the exploratory evaluation
of the combination of variables was planned before the initiation
of any analysis.
In previous studies, the sex-specific prevalence rates of the five
known risk factors have been evaluated separately. The reflux
prevalence has not been observed to be higher in males (Locke
et al, 1997; Nilsson et al, 2004), an observation confirmed by this
study. Findings of the national surveys of BMI in the United States
(Ogden et al, 2006) and Europe (Andreyeva et al, 2007) are
consistent with the prevalence pattern observed in this study, that
is, a higher BMI in men. Our finding of a lower frequency of non-
smoking in females is in line with most previous reports (CDC,
2007), although the prevalence rates in Sweden, especially at
younger ages, have more recently been observed to be higher in
women (Ali et al, 2009). In our study, women had, on an average, a
longer education, whereas previous research indicated a more
similar sex distribution regarding the number of years of formal
education (Molarius et al, 2007). The use of NSAIDs and aspirin
was more common in women than in men, which is supported by
some previous data with regard to aspirin (Larsson et al, 2006).
Thus, the external validity of our study seems to be adequate.
Indeed, the result that reflux seems to be less common in men
might be a product of the comparatively high average age of
participants in this study, as reflux prevalence in older men as
compared with older women has previously been shown to be
Table 2 Sex-specific prevalence rates and results of logistic regression analyses
Men: N¼3220
(65.6%)
Women: N¼1686
(34.4%)
Logistic
model
a
Risk factor combination N (%) N (%) OR (95% CI)
Reflux
b and BMI (kgm
 2)
Reflux-negative, BMIo25 965 (30.0) 645 (38.3) 1.00 (reference)
Reflux-positive, BMIX25 211 (6.6) 139 (8.2) 0.98 (0.77–1.24)
Reflux
b, BMI (kgm
 2), and smoking
Reflux-negative, BMIo25, never smoker 482 (15.0) 334 (19.8) 1.00 (reference)
Reflux-positive, BMIX25, ever smoker 117 (3.6) 62 (3.7) 1.27 (0.90–1.78)
Reflux
b, BMI (kgm
 2), and SES
Reflux-negative, BMIo25, education 49 years 424 (13.2) 293 (17.4) 1.00 (reference)
Reflux-positive, BMIX25, educationp9 years 131 (4.1) 88 (5.2) 0.90 (0.66–1.24)
Reflux
b, BMI (kgm
 2), and NSAIDs
Reflux-negative, BMIo25, ever use of NSAIDs 267 (8.3) 204 (12.1) 1.00 (reference)
Reflux-positive, BMIX25, never use of NSAIDs 97 (3.0) 45 (2.7) 1.62 (1.09–2.42)
Reflux
b, BMI (kgm
 2), smoking, and SES
Reflux-negative, BMIo25, never smoker, education 49 years 244 (7.6) 160 (9.5) 1.00 (reference)
Reflux-positive, BMIX25, ever smoker, education p9 years 72 (2.2) 36 (2.1) 1.17 (0.74–1.83)
Reflux
b, BMI (kgm
 2), smoking, and NSAIDs
Reflux-negative, BMIo25, never smoker, ever use of NSAIDs 120 (3.7) 113 (6.7) 1.00 (reference)
Reflux-positive, BMIX25, ever smoker, never use of NSAIDs 50 (1.6) 18 (1.1) 2.59 (1.42–4.72)
Reflux
b, BMI (kgm
 2), SES, and NSAIDs
Reflux-negative, BMIo25, education 49 years, ever use of NSAIDs 95 (3.0) 86 (5.1) 1.00 (reference)
Reflux-positive, BMIX25, education p9 years, never use of NSAIDs 60 (1.9) 27 (1.6) 1.79 (1.04–3.10)
Reflux
b, BMI (kgm
 2), smoking, SES, and NSAIDs
Reflux-negative, BMIo25, education 49 years, ever use of NSAIDs, never smoker 47 (1.5) 47 (2.8) 1.00 (reference)
Reflux-positive, BMIX25, education p9 years, never use of NSAIDs, ever smoker 31 (1.0) 10 (0.6) 2.76 (1.21–6.32)
Abbreviations: BMI¼body mass index; CI¼confidence interval; N¼number; NSAID¼non-steroidal anti-inflammatory drug; OR¼odds ratio; SES¼socioeconomic status.
Sex-specific prevalence rates and results of logistic regression analyses with OR and 95% CIs values, in a randomly selected sample of 4906 Swedish citizens, using predefined
combinations of risk factors as exposures and male sex as outcome.
aUsing male sex as outcome and adjusted for age only.
bGastro-oesophageal reflux disease, defined as at least
weekly symptoms of acid regurgitation and/or heartburn and/or weekly use of reflux treatment such as proton pump inhibitors, antacids, H2-blockers, etc.
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the multivariable analysis revealed small but significant differences
in separate risk factor exposure, favouring an increased exposure
in men. Putting these results into perspective, population
attributable risks were calculated (Levin, 1953; Taylor, 1977) for
the main exposures, namely, reflux, high BMI, and tobacco
smoking, using another Swedish database, incorporating oeso-
phageal adenocarcinoma data (Lofdahl et al, 2008). For the
presence of reflux disease, a BMI value 425kgm
 2, and ever
smoking, these attributable risks were 20, 40, and 43% for men and
33, 45, and 49% for women, respectively.
The finding that a combination of the two main risk factors,
reflux disease and high BMI, even when smoking status was
included, did not result in significant associations with male sex,
warrants a comment. The absence of clustering of these risk factors
in men might be explained by women reporting more reflux,
although overweight and ever smoking were more frequent in men.
The present study was unable to take into account different types
of overweight and reflux; for example, the predominantly
abdominal type of obesity (Corley et al, 2008) and erosive reflux
disease (Cook et al, 2005) are more common in males than in
females, and both these exposures have been shown to be more
harmful with regard to carcinogenesis (Cook et al, 2005).
When combining all risk factors to evaluate clustering, the data
in this study indicate predominance in men, which seems to be
driven mainly by differential NSAID use in men and women, a
comparatively weak and uncertain aetiological factor for this
cancer, without which no significant difference could be discerned.
There is mounting evidence that the male predominance in
oesophageal adenocarcinoma is age specific, wherein the highest
incidence rate ratios are observed at younger ages (Cook et al,
2009; Derakhshan et al, 2009; Rutegard et al, 2010). This may
reflect changes during and after menopause, and therefore the
cutoff of 50 years was attempted for stratification. However, the
sample size only allowed the use of the sample median of 65 years,
which may not be entirely appropriate from a biological
perspective. Nevertheless, it seems that a high BMI value is even
more prevalent in men at younger age. This is intriguing,
particularly as some evidence indicates that this high BMI value
in men confers higher risks of oesophageal adenocarcinoma
compared with women (Ryan et al, 2006).
This first and large population-based study with an unselected
sampling of participants indicates that exposure to some, but not
all, established risk factors for oesophageal adenocarcinoma is
overrepresented in males compared with females. The male
preponderance to simultaneous exposure to all risk factors is
mainly due to differential NSAID use in men and women. Our
findings seem unlikely to explain the male predominance.
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Table 3 Age-stratified sex-specific prevalence rates and results of logistic regression analyses
Agep65 years Age 465 years
Men: N¼1519
(63.7%)
Women: N¼865
(36.3%) Full model
a
Men: N¼1701
(67.4%)
Women: N¼821
(32.6%) Full model
a
Selected risk factors N (%) N (%) OR (95% CI) N (%) N (%) OR (95% CI)
Reflux
b
No 1319 (86.8) 716 (82.8) 1.00 (reference) 1392 (81.8) 585 (71.3) 1.00 (reference)
Yes 147 (9.7) 112 (12.9) 0.70 (0.53–0.92) 183 (10.8) 115 (14.0) 0.69 (0.53–0.90)
Body Mass Index
o25 (normal weight) 513 (33.8) 453 (52.4) 1.00 (reference) 607 (35.7) 337 (41.0) 1.00 (reference)
25–30 (overweight) 734 (48.3) 269 (31.1) 2.41 (1.99–2.93) 774 (45.5) 269 (32.8) 1.63 (1.33–1.99)
X30 (obese) 219 (14.4) 110 (12.7) 1.74 (1.33–2.29) 216 (12.7) 144 (17.5) 0.87 (0.67–1.13)
Tobacco smoking status
Never 700 (46.1) 405 (46.8) 1.00 (reference) 759 (44.6) 485 (59.1) 1.00 (reference)
Former smoker 522 (34.4) 281 (32.5) 1.04 (0.86–1.27) 688 (40.4) 199 (24.2) 2.18 (1.79–2.67)
Current smoker 265 (17.4) 154 (17.8) 0.97 (0.76–1.24) 180 (10.6) 79 (9.6) 1.41 (1.05–1.90)
Formal education (proxy for SES)
412 years 460 (30.3) 356 (41.2) 1.00 (reference) 311 (18.3) 119 (14.5) 1.00 (reference)
9–12 years 249 (16.4) 89 (10.3) 2.10 (1.58–2.80) 148 (8.7) 30 (3.7) 2.14 (1.35–3.37)
p9 years 771 (50.8) 399 (46.1) 1.38 (1.13–1.67) 1182 (69.5) 635 (77.3) 0.77 (0.61–0.98)
NSAID use
Daily 608 (18.9) 356 (21.1) 1.00 (reference) 441 (25.9) 256 (31.2) 1.00 (reference)
Weekly 216 (6.7) 170 (10.1) 0.71 (0.48–1.05) 110 (6.5) 76 (9.3) 0.85 (0.61–1.21)
Monthly 217 (6.7) 156 (9.3) 0.71 (0.49–1.02) 79 (4.6) 37 (4.5) 1.15 (0.74–1.78)
No use
c 2023 (62.8) 926 (54.9) 1.26 (0.95–1.67) 946 (55.6) 388 (47.3) 1.31 (1.07–1.61)
Abbreviations: CI¼confidence interval; N¼number; NSAID¼non-steroidal anti-inflammatory drug; OR¼odds ratio; SES¼socioeconomic status. Age-stratified sex-specific
prevalence rates and results of logistic regression analyses OR and 95% CIs values, in a randomly selected sample of 4906 Swedish citizens, using predefined combinations of risk
factors as exposures and male sex as outcome.
aAdjusted for physical activity, reflux, education, body mass index, smoking status, NSAID use.
bDefined as at least weekly
symptoms of acid regurgitation and/or heartburn and/or weekly use of gastro-oesophageal reflux disease treatment such as proton pump inhibitors, antacids, or H2-blockers.
cNo use or less than once a month.
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